IL142702A0 - Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester - Google Patents

Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester

Info

Publication number
IL142702A0
IL142702A0 IL14270299A IL14270299A IL142702A0 IL 142702 A0 IL142702 A0 IL 142702A0 IL 14270299 A IL14270299 A IL 14270299A IL 14270299 A IL14270299 A IL 14270299A IL 142702 A0 IL142702 A0 IL 142702A0
Authority
IL
Israel
Prior art keywords
propylene glycol
acid ester
alkanoic acid
antiviral formulations
isopropyl alkanoic
Prior art date
Application number
IL14270299A
Other languages
English (en)
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL142702(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of IL142702A0 publication Critical patent/IL142702A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14270299A 1998-11-18 1999-11-12 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester IL142702A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803929A SE9803929D0 (sv) 1998-11-18 1998-11-18 Antiviral formulation
PCT/SE1999/002043 WO2000029027A1 (fr) 1998-11-18 1999-11-12 Formulations antivirales renfermant du propylene glycol et un ester acide alkanoique d'isopropyle

Publications (1)

Publication Number Publication Date
IL142702A0 true IL142702A0 (en) 2002-03-10

Family

ID=20413320

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14270299A IL142702A0 (en) 1998-11-18 1999-11-12 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
IL142702A IL142702A (en) 1998-11-18 2001-04-19 Antiviral formulations consisting of propylene glycol ester of alkanoic isopropyl acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142702A IL142702A (en) 1998-11-18 2001-04-19 Antiviral formulations consisting of propylene glycol ester of alkanoic isopropyl acid

Country Status (21)

Country Link
EP (1) EP1131104B1 (fr)
JP (2) JP2002529520A (fr)
KR (1) KR100608963B1 (fr)
CN (1) CN1160128C (fr)
AR (1) AR023705A1 (fr)
AT (1) ATE288283T1 (fr)
AU (1) AU772435B2 (fr)
CA (1) CA2351463C (fr)
DE (1) DE69923584T2 (fr)
DK (1) DK1131104T3 (fr)
EG (1) EG23853A (fr)
ES (1) ES2233104T3 (fr)
HK (1) HK1042440B (fr)
IL (2) IL142702A0 (fr)
MY (1) MY122397A (fr)
NZ (1) NZ511832A (fr)
PT (1) PT1131104E (fr)
SE (1) SE9803929D0 (fr)
TW (1) TW589191B (fr)
WO (1) WO2000029027A1 (fr)
ZA (1) ZA200103335B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04004532A (es) 2001-11-19 2004-08-11 Medigene Ag Medicamento para el tratamiento de enfermedades tumorales y virales de la piel.
WO2005037300A1 (fr) 2003-10-09 2005-04-28 Medigene Ag Utilisation d'un polyphenol pour le traitement d'une lesion cancereuse ou precancereuse de la peau
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers

Also Published As

Publication number Publication date
TW589191B (en) 2004-06-01
DE69923584D1 (de) 2005-03-10
MY122397A (en) 2006-04-29
HK1042440A1 (en) 2002-08-16
IL142702A (en) 2006-07-05
KR20010075720A (ko) 2001-08-09
EP1131104B1 (fr) 2005-02-02
ZA200103335B (en) 2002-07-24
HK1042440B (zh) 2005-04-29
AU772435B2 (en) 2004-04-29
EP1131104A1 (fr) 2001-09-12
CN1160128C (zh) 2004-08-04
ATE288283T1 (de) 2005-02-15
AU1436400A (en) 2000-06-05
JP2011157392A (ja) 2011-08-18
NZ511832A (en) 2003-09-26
AR023705A1 (es) 2002-09-04
DK1131104T3 (da) 2005-03-14
CN1326364A (zh) 2001-12-12
SE9803929D0 (sv) 1998-11-18
ES2233104T3 (es) 2005-06-01
DE69923584T2 (de) 2006-03-23
CA2351463C (fr) 2009-10-13
JP5420583B2 (ja) 2014-02-19
WO2000029027A1 (fr) 2000-05-25
EG23853A (en) 2007-11-06
PT1131104E (pt) 2005-03-31
JP2002529520A (ja) 2002-09-10
KR100608963B1 (ko) 2006-08-09
CA2351463A1 (fr) 2000-05-25

Similar Documents

Publication Publication Date Title
SG93823A1 (en) Aryl-acrylic acid esters
AP2001002366A0 (en) Systems and methods for aerosolizing pharmacetical formulations
IS6205A (is) Lyfja- og næringarsamsetningar sem innihalda nauðsynlegar fitusýrur og hómósystein-lækkandi miðla
GB9403857D0 (en) Fatty acid derivatives
EP1121150A4 (fr) Desaturase d'acide gras delta 6
SG79255A1 (en) Pharmaceutical formulations
IL139635A0 (en) New 3-aryl propionic acid derivatives and analogs
HUP0000937A3 (en) New fatty acid derivatives
HK1049798B (zh) 固體類脂製劑
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
GB2349336B (en) Pesticidal composition based on 2-methoxycarbonyl-4-chlorotrifluoromethanesulphonanilide & an ester of an alkanedicarboxylic, citric or fatty acid
IL142702A0 (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
AU3449299A (en) Fatty acid analogs and prodrugs
SI1131104T1 (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
HUP0103334A3 (en) Substituted cinnamic acids and cinnamic acid esters
GB2329086B (en) Low power RF amplifier
IL125731A0 (en) Fatty acid derivatives
HUP0103975A3 (en) Phosphoric acid esters
HK1016590A1 (en) Pharmaceutical compositions comprising famciclovir monohydrate
GB9621293D0 (en) Formulations containing unsaturated fatty acids
GB9615441D0 (en) Benzoylpropionic acid ester derivatives
GB9618543D0 (en) Fatty acid analogues
GB9700383D0 (en) Fatty acid treatent
ITMI950156A0 (it) Composti di estere di propilenglicol mondalchiletere e procedimento per la loro preparazione
GB9821168D0 (en) Anti-inflammatory pharmaceutical formulations

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed